CAITLIN FEATHERSTON: Open Payments
NPI 1811738461 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,424 in 58 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $483 · 2025 $1,424
Food & beverage: $1,406Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $221 |
| Eisai Inc. | 5 | $164 |
| UCB, Inc. | 6 | $146 |
| EMD Serono, Inc. | 6 | $141 |
| ARGENX US, INC. | 7 | $141 |
| Novartis Pharmaceuticals Corporation | 4 | $118 |
| Medtronic, Inc. | 1 | $102 |
| Alexion Pharmaceuticals, Inc. | 3 | $88 |
| Amneal Pharmaceuticals LLC | 2 | $52 |
| Janssen Biotech, Inc. | 2 | $47 |
Products named: Leqembi, KESIMPTA, Briviact, UBRELVY, INTELLIS ADAPTIVESTIM, ULTOMIRIS, VYVGART, BOTOX.
Industry payments across FL — which companies pay providers there.
